Global Colon Cancer Association (GCCA) shared on LinkedIn:
“Thank you from all of us at GCCA.
Our webinar, HER2 and Colorectal Cancer:
What Advocates Need to Know, brought advocates from across our global community together to explore what HER2 means in colorectal cancer, why biomarker testing matters, and how advocates can help patients ask the right questions.
Thank you to everyone who joined us, and to our outstanding speakers, Dr. John Strickler (Duke University) and patient advocate Elle Charnisky, with moderation by GCCA President Nicole Sheahan.
A special thank you to Pfizer for supporting this educational program.”
Other articles about GCCA on OncoDaily.